Company news
Cyduct Diagnostics Inc. (OTC:CYDX) news
Cyduct Diagnostics Inc. news releases on 6ix. Latest, Aug 12, 2026: CYDUCT Positioned to Help Define the Next Frontier in Precision Breast Health
Press releases & updates
CYDUCT Positioned to Help Define the Next Frontier in Precision Breast Health
August 11, 2026
CYduct Diagnostics Positions Intraductal Platform to Address Multi-Billion-Dollar Gap in Breast Cancer Screening
August 10, 2026
CYDUCT Welcomes the Shift Toward Precision Molecular Testing as Demand for Personalized Breast Health Insights Accelerates
August 9, 2026
CYDUCT Diagnostics Launches New Corporate Branding Strategy Ahead of Planned 2027 Market Expansion
August 6, 2026
CYDUCT Diagnostics Announces Promising Preliminary Results Supporting Its microfluidic pad for Nipple Aspirate Fluid Collection
August 4, 2026
Correction: CYduct Diagnostics Granted Patent for Precision Medicine Test
December 15, 2025
Groundbreaking Study on Risk Assessment of Breast Cancer Aims to Revolutionize Diagnosis and Treatment
April 8, 2025
Cyduct Diagnostics To Participate at the 10th Annual Yale Innovation Summit
May 15, 2024
CYduct Diagnostics Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer
April 1, 2024
CYduct Diagnostics Proudly Supports the "Find It Early Act" to Advance Women's Health
October 30, 2023
CYduct Diagnostics Inc. Advocates for Breast Cancer Awareness Month: Pioneering Innovation and Early Detection
October 18, 2023
Cyduct Diagnostics Recognizes a Visionary Leader in Breast Health: Dr. Susan Love
July 31, 2023
CYduct Diagnostics Sponsors the Dr. Susan Love Foundation for Breast Cancer Research's 15th Annual Walk With Love
June 27, 2023
Cyduct Diagnostics Inc. Proudly Sponsors Camp Breastie 2023
June 7, 2023
CYduct Diagnostics Recognized as April's "Innovator of the Month" by U.S. Senator Chris Murphy
May 3, 2023
CYduct Diagnostics Inc. Clinical Team Wins Grant and Takes the Stage at the Dr. Susan Love Foundation’s 11th International Symposium on the Human Breast
February 21, 2023
CYduct Diagnostics Inc. Provides a Corporate Outlook for 2023
January 18, 2023
CYduct Diagnostics Inc. Completes Audit of its Consolidated Financial Statements
October 3, 2022
CYduct Diagnostics, Inc. Issues Annual Shareholder Update and Letter from the President
August 17, 2022
CYduct Diagnostics, Inc. Joins Connecticut's Biosciences Community
May 8, 2022
CYduct Diagnostics, Inc. Announces the Appointment of Anthony L.G., PLLC as Corporate and Securities Counsel
November 14, 2021
CYduct Diagnostics, Inc. Announces Year-End Financial Results for Fiscal 2021
September 29, 2021
Cyduct Diagnostics Inc. Retains TPS Thayer, a PCAOB Registered Certified Public Accounting Firm
June 23, 2021
CYduct Diagnostics, Inc. Completes Strategic Acquisition
May 11, 2021
CYduct Diagnostics, Inc. Enters Proteomic Research Agreement With Yale University
April 4, 2021
CYduct Diagnostics, Inc. Announces OTC Ticker Symbol Change to "CYDX"
December 28, 2020
CYduct Diagnostics, Inc. Signs LOI for Strategic Asset Acquisition
December 1, 2020
Solos Endoscopy, Inc. To Complete Capital Restructuring and Name Change
November 29, 2020
Solos Endoscopy, Inc. Acquires Assets of CYduct, LLC
November 19, 2020
Solos Endoscopy's MammoView(R) Now for use with Low Temperature Sterilization System
September 15, 2020
Solos Endoscopy, Inc. Offers Face Shields for its Customers During the COVID-19 Crisis
July 21, 2020
Solos Endoscopy, Inc. Reports Improved Results for Fiscal Year 2019
February 26, 2020
Solos Endoscopy, Inc. Will Look to Become a Women’s Healthcare Focused Company
January 14, 2020
SNDY to Focus on Breast Cancer Market
January 14, 2020
Solos Endoscopy, Inc. Appoints Distributor to Expand Their MammoView Sales Into India
October 17, 2019
Solos Introduces MammoView at ABSICON
September 23, 2019
Solos Attends ABSICON 2019
September 10, 2019
Solos Endoscopy Eliminates Its Derivative Liability
July 23, 2019
Solos Reports 1st Qtr Increases
May 16, 2019
Solos Endoscopy Further Reduces its Outstanding Convertible Preferred Stock
October 24, 2018
Solos Continues Restructuring Outstanding Preferred Stock
July 24, 2018
Solos' Restructures Outstanding Preferred Stock
June 20, 2018
New Office Location
March 13, 2018
OTC Markets Group Announces Lists of Compliance Downgrades and Caveat Emptor Designations for the Month of November
December 4, 2017
Current Report
July 27, 2017
Bob Segersten resigns from Solos Endoscopy Corp.
June 14, 2017
AMG Acquires Control Share of Solos Endoscopy, Inc.
June 9, 2017
Solos Endoscopy, Inc. Retains Consulting Firm
January 17, 2017
Solos Endoscopy Sales Increase by 20% for First Quarter 2016
May 12, 2016
Solos Endoscopy Fulfills Backorders for MammoView(R) Ductoscopy Instruments
March 17, 2016